Cadrenal Therapeutics, Inc.
Pharmaceutical company · Ponte Vedra, Florida, United States · Nasdaq: CVKD
Cadrenal Therapeutics, Inc. is a pharmaceutical company headquartered in Ponte Vedra, Florida, United States. Its earliest recorded incorporation is in 2022. Its shares trade on Nasdaq under the ticker CVKD. It has reported private securities offerings to the US SEC, most recently $7.9 million sold in a notice filed in 2026.
Cadrenal Therapeutics at a glance
What does Cadrenal Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $7.9 million sold (2026).
Frequently asked questions about Cadrenal Therapeutics
Where is Cadrenal Therapeutics headquartered?
Cadrenal Therapeutics, Inc. is headquartered in Ponte Vedra, Florida, United States.
What does Cadrenal Therapeutics do?
Cadrenal Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Cadrenal Therapeutics a public company?
Yes. Cadrenal Therapeutics, Inc. trades on Nasdaq under the ticker CVKD.
When was Cadrenal Therapeutics founded?
The earliest incorporation on record for Cadrenal Therapeutics, Inc. is in 2022, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences